Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 36, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 25 September 2026 - 10:50

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 36, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/rinvoq

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters